EP3597646
Meðferðar-efnasambönd sem eru nytsamleg til fyrirbyggjandi eða læknandi meðhöndlunar á HIV-veirusýkingu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.8.2017EP published:
21.6.2023EP application number:
19178148.3
EP translation filed:
4.9.2023Grant published:
15.10.2023EPO information:
European Patent Register
Max expiry date:
16.8.2037Expiry date:
16.8.2026Next due date:
31.8.2026
Title in English:
THERAPEUTIC COMPOUNDS USEFUL FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF AN HIV VIRUS INFECTIONLanguage of the patent:
English
Timeline
Today
17.8.2017EP application
21.6.2023EP Publication
4.9.2023Translation submitted
15.10.2023Registration published
16.8.2026Expires
Owner
Name:
Gilead Sciences, Inc.Address:
333 Lakeside Drive, Foster City, CA 94404, US
Inventor
Name:
GRAUPE, MichaelAddress:
Foster City, CA 94404, US
Name:
HENRY, Steven J.Address:
Foster City, CA 94404, US
Name:
LINK, John O.Address:
Foster City, CA 94404, US
Name:
ROWE, Charles WilliamAddress:
Foster City, CA 94404, US
Name:
SAITO, Roland D.Address:
Foster City, CA 94404, US
Name:
SCHROEDER, Scott D.Address:
Foster City, CA 94404, US
Name:
STEFANIDIS, DimitriosAddress:
Foster City, CA 94404, US
Name:
TSE, Winston C.Address:
Foster City, CA 94404, US
Name:
ZHANG, Jennifer R.Address:
Foster City, CA 94404, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662377312 PDate:
19.8.2016Country:
US
Number:
201762457555 PDate:
10.2.2017Country:
US
Classification
Categories:
C07D 401/14, A61K 31/537, A61P 31/18
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 25.8.2023
Expires: 16.8.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.7.2024
Expires: 16.8.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.8.2025
Expires: 16.8.2026
Payer: Árnason Faktor ehf.